This CRO (Contract Research Organization) has a 25+ year history and a dedicated team.
Let's dive into the details:
This business is focused on one key service:
Offering full-spectrum clinical trial management, from pre-clinical to Phase 4.
With their proprietary tech and seasoned team, they’ve built a strong reputation in the pharmaceutical and medical device industries.
Here’s what sets them apart…
Strategic presence.
Prosoft Clinical serves clients across the U.S., Canada, and Europe, providing a diversified revenue stream.
Their proprietary systems like eDC, IWRS, and AdaptIQ not only streamline trials but also have the potential for lucrative licensing opportunities.
Plus…
The owner is nearing retirement, making this an ideal acquisition opportunity.
With a strong $10M backlog in signed contracts and $1M in new consulting revenue, this business is positioned for significant growth.
But there’s more…
Despite a dip during the COVID-19 pandemic, the company is on track to bounce back in 2024, potentially exceeding pre-pandemic revenue levels of $7M.
The pipeline is strong, and with the right marketing strategy, the sky's the limit.
What’s exciting?
There’s untapped potential in licensing their tech and expanding into new therapeutic areas beyond their current focus.
Plus, their client base, built largely on word of mouth, shows the trust and satisfaction they've earned over the years.
Considering this?
The current owners are committed to ensuring a smooth transition and are even open to staying on for a period to help scale the business.
With the right vision, this could be a game-changer in the CRO industry.
Enjoyed this breakdown?
Drop a comment or DM me “clinical” and I’ll tell you how you can access this deal and others like it.